{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:00:24Z","timestamp":1785200424468,"version":"3.55.0"},"reference-count":19,"publisher":"BMJ","funder":[{"DOI":"10.13039\/100032091","name":"Royal Free Charity","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100032091","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["155694"],"award-info":[{"award-number":["155694"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,6,14]]},"DOI":"10.1136\/gutjnl-2026-339715","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:25:25Z","timestamp":1785198325000},"page":"gutjnl-2026-339715","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["A patient-driven agenda for liver cirrhosis research"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct03789825","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-6632","authenticated-orcid":false,"given":"Oliver","family":"Tavabie","sequence":"first","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Crisp","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Allen","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement and Engagement Representative, Patient and Public Involvement and Engagement Representative, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ashborn","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement and Engagement Representative, Patient and Public Involvement and Engagement Representative, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Hebditch","sequence":"additional","affiliation":[{"name":"British Liver Trust, Ringwood, Hampshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-359X","authenticated-orcid":false,"given":"Gautam","family":"Mehta","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Health, University College London, London, UK"},{"name":"Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"2026072717252187000_gutjnl-2026-339715v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"2026072717252187000_gutjnl-2026-339715v1.2","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026072717252187000_gutjnl-2026-339715v1.3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jhep.2018.12.021","article-title":"No safe level of alcohol consumption - Implications for global health","volume":"70","author":"Mehta","year":"2019","journal-title":"J Hepatol"},{"key":"2026072717252187000_gutjnl-2026-339715v1.4","unstructured":"Office for Health Improvement and Disparities . Liver Disease Profiles, 2023. Available: https:\/\/fingertips.phe.org.uk\/profile\/liver-disease [Accessed 24 Mar 2024]."},{"key":"2026072717252187000_gutjnl-2026-339715v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(25)00047-7"},{"key":"2026072717252187000_gutjnl-2026-339715v1.6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cgh.2023.04.012","article-title":"Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study","volume":"22","author":"Abdelmalek","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026072717252187000_gutjnl-2026-339715v1.7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/HEP.0000000000000607","article-title":"A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis","volume":"79","author":"Rinella","year":"2024","journal-title":"Hepatology"},{"key":"2026072717252187000_gutjnl-2026-339715v1.8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","article-title":"Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial","volume":"15","author":"Shi","year":"2021","journal-title":"Hepatol Int"},{"key":"2026072717252187000_gutjnl-2026-339715v1.9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjcard.2014.04.018","article-title":"Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial","volume":"114","author":"Ferdinand","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026072717252187000_gutjnl-2026-339715v1.10","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2024-102710"},{"key":"2026072717252187000_gutjnl-2026-339715v1.11","doi-asserted-by":"crossref","DOI":"10.3310\/nihropenres.13669.1","article-title":"Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UK","volume":"4","author":"Crisp","year":"2024","journal-title":"NIHR Open Res"},{"key":"2026072717252187000_gutjnl-2026-339715v1.12","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/apt.70080","article-title":"Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial)","volume":"61","author":"Tripathi","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"2026072717252187000_gutjnl-2026-339715v1.13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jama.2024.27441","article-title":"Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial","volume":"333","author":"Pose","year":"2025","journal-title":"JAMA"},{"key":"2026072717252187000_gutjnl-2026-339715v1.14","first-page":"265","article-title":"Preventing the progression of cirrhosis to decompensation and death","volume":"22","author":"Villanueva","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026072717252187000_gutjnl-2026-339715v1.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100993","article-title":"AlcoChange: A digital therapeutic for patients with alcohol-related liver disease","volume":"6","author":"Mehta","year":"2024","journal-title":"JHEP Rep"},{"key":"2026072717252187000_gutjnl-2026-339715v1.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.s54","article-title":"The UK\u2019s Health Data Research Service can unlock major public benefit-if grounded in real world care and internationally connected","volume":"392","author":"Buchan","year":"2026","journal-title":"BMJ"},{"key":"2026072717252187000_gutjnl-2026-339715v1.17","unstructured":"Dementia trials accelerator, 2025. Available: https:\/\/web.dementia-trials.healthdatagateway.org\/en [Accessed 4 Jun 2026]."},{"key":"2026072717252187000_gutjnl-2026-339715v1.18","unstructured":"Accelerating clinical trials in the EU, 2026. Available: https:\/\/accelerating-clinical-trials.europa.eu\/index_en [Accessed 4 Jun 2026]."},{"key":"2026072717252187000_gutjnl-2026-339715v1.19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.imed.2025.08.003","article-title":"A retrospective validation of a federated machine learning framework (Hepa-FedBoost) for improving liver cancer computed tomography diagnosis across heterogeneous hospital networks","volume":"6","author":"Li","year":"2026","journal-title":"Intelligent Medicine"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-339715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:25:28Z","timestamp":1785198328000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-339715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":19,"alternative-id":["10.1136\/gutjnl-2026-339715"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-339715","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}